Celldex Therapeutics

PriceCelldex Therapeutics

CLDX

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Historical stock price chart and annual return over the past years

996%

5 years

% Total

CLDX
61%

5 years

Annual Return

CLDX